Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001632295-25-000005
Filing Date
2025-12-15
Accepted
2025-12-15 16:15:11
Documents
1
Period of Report
2025-12-12

Document Format Files

Seq Description Document Type Size
1 form4-12152025_041207.html 4  
1 form4-12152025_041207.xml 4 4089
  Complete submission text file 0001632295-25-000005.txt   5955
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KYTHERA BIOPHARMACEUTICALS, INC. 30930 RUSSELL RANCH ROAD, 3RD FLOOR WESTLAKE VILLAGE CA 91362
Business Address
Little Elisabeth Sandoval (Reporting) CIK: 0001632295 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 251571765